Download PDF
1
/
Pages
Previous article
Go back to website
Next article
If you have problems to see the content please click here
Other users also viewed these articles
Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio
Anna Vidal-Alabró; Helena Colom; Pere Fontova; Gema Cerezo; Edoardo Melilli; Nuria Montero; Ana Coloma; Anna Manonelles; Alex Favà; Josep M. Cruzado; Joan Torras; Josep M. Grinyó; Nuria Lloberas;
Nefrologia (English Version). 2024;44:204-16
Use of glucagon-like peptide type 1 receptor agonists in kidney transplant recipients
Luis Alberto Vigara; Florentino Villanego; Cristhian Orellana; Myriam Eady; María Gabriela Sánchez; Marta Alonso; María Belén García; José Manuel Amaro; Teresa García; Auxiliadora Mazuecos;
Nefrologia (English Version). 2024;44:885-93
Randomized clinical trial of non-antibiotic prophylaxis with d-Mannose plus Proanthocyanidins vs. Proanthocyanidins alone for urinary tract infections and asymptomatic bacteriuria in de novo kidney transplant recipients: The Manotras study
Melissa Rau; Adrian Santelli; Sara Martí; María Isabel Díaz; Nuria Sabé; María Fiol; Luis Riera; Begoña Etcheverry; Sergi Codina; Ana Coloma; Anna Carreras-Salinas; Carmen Ardanuy; Josep M. Cruzado; Edoardo Melilli;
Nefrologia (English Version). 2024;44:408-16